Banyan BioInnovations Capital Fund I LP
RaisingEmerging manager
Raising: Form D filed Jun 2026 reports an open-ended (indefinite) offering
No contact route found yet.
Limited data: built from SEC filings only.
- Vintage
- 2026
- Fund size
- $102M (Form D)
- Stages
- Not stated
- Sectors
- Not stated
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$1.02M to $1.7M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Barbara White, President
- Peter Shanley, COO
- Geoffrey Meyerson, CEO
- Andrew Meyerson, Managing Director
- Daniel Brog, Managing Director
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
No quoted evidence from the firm's website yet.
06 · Sources
Last verified: Oct 25, 2026